Hypogonadism in patients with chronic obstructive pulmonary disease: relationship with airflow limitation, muscle weakness and systemic inflammationFootnote

Peer review under responsibility of Alexandria University Faculty of Medicine.

Footnote

Available online 24 February 2015

References

• H.C.KimM.MofarrahiS.N.HussainSkeletal muscle dysfunction in patients with chronic obstructive pulmonary diseaseInt J Chronic Obstruct Pulm Dis342008637658
   PubMedGoogle Scholar
• F.LaghiW.E.LangbeinA.Antonescu-TurcuA.JubranC.BammertM.J.TobinRespiratory and skeletal muscles in hypogonadal men with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med17162005598605
   Web of Science ®Google Scholar
• R.DebigareK.MarquisC.H.CoteR.R.TremblayA.MichaudP.LeBlancCatabolic/anabolic balance and muscle wasting in patients with COPDChest124120038389
   PubMed Web of Science ®Google Scholar
• A.KaparianosE.ArgyropoulouG.EfremidisK.SpiropoulosSex hormone alterations and systemic inflammation in a group of male COPD smokers and their correlation with the +138 insA/delA endothelin-1 gene polymorphism. A case-control studyEur Rev Med Pharmacol Sci1510201111491157
   Web of Science ®Google Scholar
• D.M.BiskobingCOPD and osteoporosisChest12122002609620
   PubMed Web of Science ®Google Scholar
• K.MarquisR.DebigareY.LacasseP.LeBlancJ.JobinG.CarrierMidthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16662002809813
   PubMed Web of Science ®Google Scholar
• F.LaghiA.Antonescu-TurcuE.CollinsJ.SegalD.E.TobinA.JubranHypogonadism in men with chronic obstructive pulmonary disease: prevalence and quality of lifeAm J Respir Crit Care Med17172005728733
   Web of Science ®Google Scholar
• P.J.SnyderHypogonadism in elderly men–what to do until the evidence comesN Engl J Med35052004440442
   Web of Science ®Google Scholar
• F.LaghiLow testosterone in chronic obstructive pulmonary disease: does it really matter?Am J Respir Crit Care Med1729200510691070
   Web of Science ®Google Scholar
• S.SpencerP.M.CalverleyP.Sherwood BurgeP.W.JonesHealth status deterioration in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med16312001 Jan122128
   PubMed Web of Science ®Google Scholar
• V.BalasubramanianS.NaingHypogonadism in chronic obstructive pulmonary disease: incidence and effectsCurr Opin Pulm Med1822012112117
   Web of Science ®Google Scholar
• T.TroostersR.GosselinkM.DecramerShort- and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: a randomized trialAm J Med10932000207212
   PubMed Web of Science ®Google Scholar
• R.DebigareC.H.CoteF.MaltaisPeripheral muscle wasting in chronic obstructive pulmonary disease. Clinical relevance and mechanismsAm J Respir Crit Care Med1649200117121717
   PubMed Web of Science ®Google Scholar
• M.A.SpruitR.GosselinkT.TroostersA.KasranG.Gayan-RamirezP.BogaertsMuscle force during an acute exacerbation in hospitalized patients with COPD and its relationship with CXCL8 and IGF-IThorax5892003752756
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management, and prevention of COPD. <http://www.goldcopd.org>; 2014.
   Google Scholar
• ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–7.
   Google Scholar
• V.BrusascoR.CrapoG.ViegiStandardization of spirometry. ‘‘ATS/ERS task force: standardisation of lung function testing” (Number 2)Eur Respir J262005319338
   PubMed Web of Science ®Google Scholar
• L.VerdijkL.LoonK.MeijerH.SavelbergOne-repetition maximum strength test represents a valid means to assess leg strength in vivo in humansJ Sports Sci27120095968
   PubMed Web of Science ®Google Scholar
• A.B.AraujoA.B.O’DonnellD.J.BrambillaPrevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging StudyJ Clin Endocrinol Metab89200459205926
   PubMed Web of Science ®Google Scholar
• S.M.HarmanE.J.MetterJ.D.TobinLongitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of AgingJ Clin Endocrinol Metab862001724731
   PubMed Web of Science ®Google Scholar
• A.VermeulenJ.M.KaufmanDiagnosis of hypogonadism in the aging maleAging Male52002170176
   PubMedGoogle Scholar
• M.Van VlietM.A.SpruitG.VerledenA.KasranE.Van HerckF.PittaHypogonadism, quadriceps weakness, and exercise intolerance in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1729200511051111
   PubMed Web of Science ®Google Scholar
• A.KamischkeD.E.KemperM.A.CastelM.LuthkeC.RolfH.M.BehreTestosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapyEur Res J11119984145
   PubMed Web of Science ®Google Scholar
• J.P.DeslypereJ.M.KaufmanT.VermeulenD.VogelaersJ.L.VandalemA.VermeulenInfluence of age on pulsatile luteinizing hormone release and responsiveness of the gonadotrophs to sex hormone feedback in menJ Clin Endocrinol Metab64119876873
   Web of Science ®Google Scholar
• J.M.KaufmanJ.P.DeslypereM.GiriA.VermeulenNeuroendocrine regulation of pulsatile luteinizing hormone secretion in elderly menJ Steroid Biochem Mol Biol3731990421430
   Web of Science ®Google Scholar
• J.M.KaufmanM.GiriJ.M.DeslypereG.ThomasA.VermeulenInfluence of age on the responsiveness of the gonadotrophs to luteinizing hormone-releasing hormone in malesJ Clin Endocrinol Metab726199112551260
   Web of Science ®Google Scholar
• J.R.GosneyAtrophy of Leydig cells in the testes of men with longstanding chronic bronchitis and emphysemaThorax4281987615619
   PubMed Web of Science ®Google Scholar
• K.MealyB.RobinsonC.F.MilletteJ.MajzoubD.W.WilmoreThe testicular effects of tumor necrosis factorAnn Surg21141990470475
   Web of Science ®Google Scholar
• P.O.CoverF.Baanah-JonesC.D.JohnJ.C.BuckinghamAnnexin 1 (lipocortin 1) mimics inhibitory effects of glucocorticoids on testosterone secretion and enhances effects of interleukin-1betaEndocrine18120023339
   Web of Science ®Google Scholar
• H.B.GaoM.H.TongY.Q.HuH.Y.YouQ.S.GuoR.S.GeMechanisms of glucocorticoid-induced Leydig cell apoptosisMol Cell Endocrinol1991–22003153163
   PubMed Web of Science ®Google Scholar
• A.M.IsidoriA.LenziRisk factors for androgen decline in older males: lifestyle, chronic diseases and drugsJ Endocrinol Invest2820051422
   PubMedGoogle Scholar
• A.shakerA.El-ShoraM.El-GammalH.A.LabibEndocrinal disturbances and systemic inflammatiom in chronic obstructive pulmonary disease (COPD)Egypt J Chest Dis Tuber61320128188
   Google Scholar
• F.PittaT.TroostersM.A.SpruitV.S.ProbstM.DecramerR.GosselinkCharacteristics of physical activities in daily life in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med17192005972977
   PubMed Web of Science ®Google Scholar
• S.BernardP.LeBlancF.WhittomG.CarrierJ.JobinR.BelleauPeripheral muscle weakness in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med15821998629634
   PubMed Web of Science ®Google Scholar
• R.CasaburiS.BhasinL.CosentinoJ.PorszaszA.SomfayM.I.LewisEffects of testosterone and resistance training in men with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med1702004870878
   PubMed Web of Science ®Google Scholar
• S.BhasinL.WoodhouseR.CasaburiA.B.SinghR.P.MacM.LeeOlder men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscleJ Clin Endocrinol Metab902005678688
   PubMed Web of Science ®Google Scholar
• G.C.DonaldsonT.A.SeemungalI.S.PatelA.BhowmikT.M.WilkinsonJ.R.HurstAirway and systemic inflammation and decline in lung function in patients with COPDChest1284200519952004
   PubMed Web of Science ®Google Scholar
• W.Q.GanS.F.ManA.SenthilselvanD.D.SinAssociation between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysisThorax5972004574580
   PubMed Web of Science ®Google Scholar
• R.GarrodJ.MarshallE.BarleyS.FredericksG.HaganThe relationship between inflammatory markers and disability in chronic obstructive pulmonary disease (COPD)Prim Care Respir J1642007236240
   PubMedGoogle Scholar
• V.M.Pinto-PlataH.MullerovaJ.F.TosoM.Feudjo-TepieJ.B.SorianoR.S.VesseyC-reactive protein in patients with COPD, control smokers and non-smokersThorax61120062328
   PubMed Web of Science ®Google Scholar
• D.G.YanbaevaM.A.DentenerM.A.SpruitJ.J.Houwing-DuistermaatD.KotzV.L.PassosIL6 and CRP haplotypes are associated with COPD risk and systemic inflammation: a case-control studyBMC Med Genet1020092333
   PubMed Web of Science ®Google Scholar
• R.BroekhuizenE.F.WoutersE.C.CreutzbergA.M.ScholsElevated CRP levels mark metabolic and functional impairment in advanced COPDThorax61120061722
   PubMed Web of Science ®Google Scholar
• H.WatzB.WaschkiC.BoehmeM.ClaussenT.MeyerH.MagnussenExtrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional studyAm J Respir Crit Care Med17772008743751
   PubMed Web of Science ®Google Scholar
• J.P.de TorresE.Cordoba-LanusC.Lopez-AguilarM.Muros de FuentesA.Montejo de GarciniA.Aguirre-JaimeCreactive protein levels and clinically important predictive outcomes in stable COPD patientsEur Respir J2752006902907
   Web of Science ®Google Scholar
• S.YendeG.W.WatererE.A.TolleyInflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjectsThorax6120061016
   PubMed Web of Science ®Google Scholar
• R.BroekhuizenE.F.WoutersE.C.CreutzbergRaised CRP levels mark metabolic and functional impairment in advanced COPDThorax6120061722
   PubMed Web of Science ®Google Scholar
• F.KaradagH.OzcanA.B.KarulSex hormone alterations and systemic inflammation in chronic obstructive pulmonary diseaseInt J Clin Pract632009275281
   PubMed Web of Science ®Google Scholar